ACT Therapy offers an effective treatment option for woman suffering from stress urinary incontinence as a result of intrinsic sphincter deficiency or a previously failed surgery.
Benefits of ACT therapy include:
- Minimally invasive
- Approximately 30-minute outpatient implant procedure
- Silicone balloon offers long-term durable prosthetic
- Non-surgical, post-operative adjustability via subcutaneous port offers
- No fixation sutures or anchors required
- Can be removed easily in an office setting
The ACT device consists of two adjustable balloon implants placed bilaterally in a periurethral position one on each side of the bladder neck. The implant procedure is minimally invasive and may be performed with general or local anesthesia in approximately 30 minutes.
Titanium ports attached via tubing to each balloon, are placed in the labia majora, allowing for transcutaneous, post-operative volume adjustment. Increasing the balloon volumes will increase coaptation of the urethra and lift the bladder neck, to improve continence. Adjustments can continue to be made to best meet the needs of the patient.
ACT is available in two sizes (8 cm and 9 cm) to fit the individual needs of your patients.
Uromedica has developed a set of dedicated implant tools. The set consists of a U-channel sheath, blunt and sharp-tipped trocars, and a tissue expanding device (TED II).
IMPORTANT SAFETY INFORMATION ABOUT ACT
The potential risks with the ACT implant procedure are similar to those for other surgical treatments for stress urinary incontinence. More detailed safety information can be found in the Instructions for Use in the device packaging or by contacting Uromedica directly.
If an infection occurs at the implant site, it can be treated with antibiotics. If a more serious side effect occurs (e.g., perforation, migration, erosion), ACT can be completely removed in an office setting with minimal risk to the patient using a topical anesthetic and small incision.